Oxymetholone
Therapeutic agent (verify pharmacological class)
What it is used for
Anaemia caused by deficient RBC production e.g. acquired aplastic or congenital anaemia. Clinical selection for Oxymetholone should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Virilism; bladder irritability; breast soreness; gynaecomastia; priapism; anaemia; iron deficiency; oedema; gastric irritation; hepatic dysfunction; suppression of clotting factors; prostatic carcinoma or prostatic hyperplasia; hepatic necrosis; hepatocellular carcinoma; peliosis hepatis; acne; chills; decrease or increase in libido; diarrhea; feeling of abdominal or stomach fullness; muscle cramps; trouble in sleeping; in males there is decreased sexual ability.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.